Neuroblastoma: Immunotherapy for Pediatric Solid Tumors
WebcastFaculty
OVERVIEW
Neuroblastoma: Immunotherapy for Pediatric Solid Tumors is organized by Baptist Health South Florida and will be held from Feb 01, 2018 - Feb 01, 2020.
The target audience for this medical event is Pediatricians, Pediatric Oncologists, Hematologists/Oncologists, Infectious Disease Pediatricians, Pediatric General Internists, Family Physicians, Neonatologists, Emergency Department Physicians and Nurse Practitioners. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Course Description :
This course will provide learners with information on selecting tumor targets, passive and active immunotherapy and the challenges in integrating immunotherapy into multimodal therapy.
Learning Objectives :
• Explain the effect of immunotherapies on adult solid tumors and the potential application and limitations of immunotherapy in children with solid tumors.
• Identify pediatric-specific immunotherapies that are both approved and in clinical trials.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Pediatricians, Pediatric Oncologists, Hematologists/Oncologists, Infectious Disease Pediatricians, Pediatric General Internists, Family Physicians, Neonatologists, Emergency Department Physicians and Nurse Practitioners. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Course Description :
This course will provide learners with information on selecting tumor targets, passive and active immunotherapy and the challenges in integrating immunotherapy into multimodal therapy.
Learning Objectives :
• Explain the effect of immunotherapies on adult solid tumors and the potential application and limitations of immunotherapy in children with solid tumors.
• Identify pediatric-specific immunotherapies that are both approved and in clinical trials.
Additional details will be posted as soon as they are available.
SPECIALITIES
OncologyImmunotherapies
Quick Links